This HTML5 document contains 107 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://dx.doi.org/10.1097/
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q30456154

rdf:type

wikibase:Item

schema:description

artigo científico (publicado na 2013) 2013年論文 article scientific 2013年论文 articolo scientifico article scientifique (publié 2013) article científic vitenskapelig artikkel научная статья 2013年論文 מאמר מדעי наукова стаття, опублікована в січні 2013 2013年論文 artikull shkencor naučni članak επιστημονικό άρθρο videnskabelig artikel (udgivet 2013) 2013年论文 tieteellinen artikkeli научни чланак artykuł naukowy vitskapeleg artikkel tudományos cikk wetenschappelijk artikel мақолаи илмӣ artigo científico 2013年论文 teaduslik artikkel bài báo khoa học mokslinis straipsnis artículo científico publicado en 2013 articol științific 2013年の論文 научна статия scientific article مقالهٔ علمی บทความทางวิทยาศาสตร์ bilimsel makale 2013년 논문 2013 nî lūn-bûn vetenskaplig artikel 2013年论文 vedecký článok научни чланак artigo científico (publicado na 2013) 2013年論文 2013 թուականի Յունուարին հրատարակուած գիտական յօդուած სამეცნიერო სტატია مقالة علمية (نشرت عام 2013) 2013年論文 ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ سائنسی مضمون 2013年论文 мақолаи илмӣ artikulong pang-agham vědecký článek 2013 թվականի հունվարին հրատարակված գիտական հոդված wissenschaftlicher Artikel artículu científicu espublizáu en 2013 scienca artikolo 2013年论文

p:P577

wds:Q30456154-0403C7F4-1D6F-4842-9C5C-4E622D21400D

wdt:P577

2013-01-01T00:00:00Z

p:P407

wds:Q30456154-D42F92F2-8B3C-43FF-BEDB-27EC0865BEDD

wdt:P407

wd:Q1860

p:P2093

wds:Q30456154-4F4FC16C-B961-4470-9671-C9FCC71AF109 wds:Q30456154-79383652-F6C2-4BB1-B0A3-63CFE7988F77 wds:Q30456154-45D75A36-0FD1-4FDB-BDFB-AF3ACBAD7D6F wds:Q30456154-25EE6590-5A42-47A5-992A-BE0E51787572

wdt:P2093

Ru-Fong J Cheng Ginger Constantine Study 3353 Investigators Eunhee Hwang

rdfs:label

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial

skos:prefLabel

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial

schema:name

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial

p:P50

wds:Q30456154-2C1CC560-43F8-4077-B6E6-1A78C12C1872

wdt:P50

wd:Q96619666

p:P1476

wds:Q30456154-49E469F4-F27E-4709-8D05-EC0AF86255AB

wdt:P1476

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial

p:P304

wds:Q30456154-EF206A4F-7FB9-4949-88FA-68C64297FADF

wdt:P304

28-37

p:P31

wds:Q30456154-ADC47F79-1BF6-4BFE-B587-2E04059724D1

wdt:P31

wd:Q13442814

p:P921

wds:Q30456154-3B084FE8-E7B2-412E-9F55-4ED26B0DAD20 wds:Q30456154-BE9A535C-7346-4467-AEE8-3F177BFBC492

wdt:P921

wd:Q269829 wd:Q6934595

p:P698

wds:Q30456154-331BEAB7-332E-4FC9-8CB0-7D5B29B6F173

wdtn:P698

n11:23010882

wdt:P698

23010882

p:P1433

wds:Q30456154-A7B7AF54-A957-4CFA-94D1-29A4E327C4AD

wdt:P1433

wd:Q6817295

p:P433

wds:Q30456154-2E262AD3-4BAF-4AB3-A0B3-40DD93525B76

p:P478

wds:Q30456154-B60D6C20-D5F1-4468-8D29-401BA5990EC3

wdt:P433

1

wdt:P478

20

p:P356

wds:Q30456154-48FC725C-ACD0-4AA3-8652-73F1E318C009

wdtn:P356

n12:GME.0B013E31826421A8

wdt:P356

10.1097/GME.0B013E31826421A8